JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy
暂无分享,去创建一个
G. Lanfranchi | A. Goldberg | M. Sandri | E. Masiero | A. Raffaello | S. Carnio | G. Milan | Donghoon Lee
[1] A. Goldberg,et al. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. , 1995, The Biochemical journal.
[2] T. Lømo,et al. Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] A. Goldberg,et al. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. , 1990, The Journal of biological chemistry.
[4] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[5] Devjit Tripathy,et al. Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. , 2008, American journal of physiology. Endocrinology and metabolism.
[6] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[7] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Bossy‐Wetzel,et al. Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression , 2000, The EMBO journal.
[9] Jiandie D. Lin,et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.
[10] D. Allen,et al. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. , 2006, American journal of physiology. Cell physiology.
[11] A. Goldberg,et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.
[12] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[13] R. Schwartz,et al. The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load. , 1991, The Journal of clinical investigation.
[14] Michael E. Greenberg,et al. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities , 1988, Cell.
[15] B. Franza,et al. Fos and jun: The AP-1 connection , 1988, Cell.
[16] E. Wagner,et al. AP-1 – Introductory remarks , 2001, Oncogene.
[17] W. Dayton,et al. Effect of sera from fed and fasted pigs on proliferation and protein turnover in cultured myogenic cells. , 1988, Journal of animal science.
[18] Ugo Carraro,et al. Functional in vivo gene transfer into the myofibers of adult skeletal muscle. , 2003, Biochemical and biophysical research communications.
[19] G. Yancopoulos,et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.
[20] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[21] A. Goldberg,et al. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.
[22] C. Mammucari,et al. Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.
[23] M. Matsui,et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.
[24] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[25] D. Glass,et al. Skeletal muscle hypertrophy and atrophy signaling pathways. , 2005, The international journal of biochemistry & cell biology.
[26] E. Olson,et al. Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor. , 1990, The Journal of biological chemistry.
[27] W. Aird,et al. The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP* , 2004, Journal of Biological Chemistry.
[28] M. Karin,et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor , 1987, Cell.
[29] E. Wagner,et al. JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression , 2000, The EMBO journal.
[30] A. Goldberg,et al. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.
[31] S. Hatakeyama,et al. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.
[32] Lung Yu,et al. Systemic treatment with protein synthesis inhibitors attenuates the expression of cocaine memory , 2010, Behavioural Brain Research.
[33] A. Goldberg,et al. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[34] W. Schaper,et al. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. , 1992, Circulation research.
[35] T. Hunter,et al. Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.
[36] Yukio Yoneda,et al. A tale of early response genes. , 2004, Biological & pharmaceutical bulletin.
[37] Luca Scorrano,et al. Mitochondrial fission and remodelling contributes to muscle atrophy , 2010, The EMBO journal.
[38] S. Kandarian,et al. Intracellular signaling during skeletal muscle atrophy , 2006, Muscle & nerve.
[39] A. Goldberg,et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[40] A. Goldberg,et al. The role of increased proteolysis in the atrophy and arrest of proliferation in serum‐deprived fibroblasts , 1984, Journal of cellular physiology.
[41] A. Goldberg,et al. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.
[42] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] A. Goldberg,et al. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.
[44] A. Clerk,et al. Glycogen synthase kinases 3α and 3β in cardiac myocytes: regulation and consequences of their inhibition , 2008 .
[45] R. Scarpulla,et al. Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Yaniv,et al. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence. , 1989, The New biologist.
[47] P. Coffer,et al. FOXO-binding partners: it takes two to tango , 2008, Oncogene.
[48] A. Clerk,et al. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition. , 2008, Cellular signalling.
[49] D. Cameron-Smith,et al. STAT3 signaling is activated in human skeletal muscle following acute resistance exercise. , 2007, Journal of applied physiology.
[50] J. L. Rosa,et al. JunB Is Involved in the Inhibition of Myogenic Differentiation by Bone Morphogenetic Protein-2* , 1998, The Journal of Biological Chemistry.
[51] C. Rommel,et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.